Organon & Co.

OGN ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
SCHEDULE 13G Aug 14, 2026
4 Aug 12, 2026 FORM 4
144 Aug 5, 2026
4 Aug 5, 2026 FORM 4
SCHEDULE 13G/A Jul 31, 2026
8-K Jul 31, 2026 FORM 8-K
10-Q Jul 31, 2026 10-Q
8-K Jul 23, 2026 8-K
DEFA14A Jul 17, 2026 DEFA14A
8-K Jul 17, 2026 8-K
DEFM14A Jun 17, 2026 DEFM14A
4 Jun 15, 2026 FORM 4
4 Jun 15, 2026 FORM 4
4 Jun 15, 2026 FORM 4
4 Jun 15, 2026 FORM 4
4 Jun 15, 2026 FORM 4
4 Jun 15, 2026 FORM 4
4 Jun 15, 2026 FORM 4
4 Jun 15, 2026 FORM 4
4 Jun 15, 2026 FORM 4
8-K Jun 11, 2026 FORM 8-K
DEFA14A Jun 11, 2026 DEFA14A
PREM14A Jun 1, 2026 PREM14A
SD May 29, 2026 FORM SD
144 May 8, 2026
← Newer Page 1 of 19 · 459 filings Older →